125 related articles for article (PubMed ID: 16764916)
1. In vitro and antinociceptive profile of HON0001, an orally active NMDA receptor NR2B subunit antagonist.
Suetake-Koga S; Shimazaki T; Takamori K; Chaki S; Kanuma K; Sekiguchi Y; Suzuki T; Kikuchi T; Matsui Y; Honda T
Pharmacol Biochem Behav; 2006 May; 84(1):134-41. PubMed ID: 16764916
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
Sharma TA; Reynolds IJ
J Pharmacol Exp Ther; 1999 May; 289(2):1041-7. PubMed ID: 10215685
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist.
Taniguchi K; Shinjo K; Mizutani M; Shimada K; Ishikawa T; Menniti FS; Nagahisa A
Br J Pharmacol; 1997 Nov; 122(5):809-12. PubMed ID: 9384494
[TBL] [Abstract][Full Text] [Related]
5. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.
Fischer G; Mutel V; Trube G; Malherbe P; Kew JN; Mohacsi E; Heitz MP; Kemp JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1285-92. PubMed ID: 9400004
[TBL] [Abstract][Full Text] [Related]
6. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
Coughenour LL; Barr BM
J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
[TBL] [Abstract][Full Text] [Related]
7. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
[TBL] [Abstract][Full Text] [Related]
8. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
Coughenour LL; Cordon JJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
[TBL] [Abstract][Full Text] [Related]
9. Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.
Nguyen KT; Claiborne CF; McCauley JA; Libby BE; Claremon DA; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Bednar B; Stump GL; Lynch JJ; Koblan KS; Liverton NJ
Bioorg Med Chem Lett; 2007 Jul; 17(14):3997-4000. PubMed ID: 17498948
[TBL] [Abstract][Full Text] [Related]
10. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
Stuchlík A; Vales K
Behav Brain Res; 2005 Apr; 159(1):163-71. PubMed ID: 15795010
[TBL] [Abstract][Full Text] [Related]
12. NMDA-NR2B subtype selectivity of stereoisomeric 2-(1,2,3,4-tetrahydro-1-isoquinolyl)ethanol derivatives.
Höfner G; Hoesl CE; Parsons C; Quack G; Wanner KT
Bioorg Med Chem Lett; 2005 May; 15(9):2231-4. PubMed ID: 15837299
[TBL] [Abstract][Full Text] [Related]
13. Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat.
Nash JE; Hill MP; Brotchie JM
Exp Neurol; 1999 Jan; 155(1):42-8. PubMed ID: 9918703
[TBL] [Abstract][Full Text] [Related]
14. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
15. Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model.
Nakazato E; Kato A; Watanabe S
Pharmacology; 2005 Jan; 73(1):8-14. PubMed ID: 15452358
[TBL] [Abstract][Full Text] [Related]
16. Interaction between M1-muscarinic and glutamatergic NMDA receptors on an inhibitory avoidance task.
Monteiro Moreira K; Lima Ferreira T; Vecchio Fornari R; Perez Figueredo LZ; Menezes Oliveira MG
Brain Res Bull; 2005 Nov; 67(6):504-8. PubMed ID: 16216700
[TBL] [Abstract][Full Text] [Related]
17. NMDA receptor antagonists antagonize the facilitatory effects of post-training intra-basolateral amygdala NMDA and physostigmine on passive avoidance learning.
Jafari-Sabet M
Eur J Pharmacol; 2006 Jan; 529(1-3):122-8. PubMed ID: 16337625
[TBL] [Abstract][Full Text] [Related]
18. Polyamine and redox modulation of [3H]MK-801 binding to N-methyl-D-aspartate receptors in the spinal cord and cerebral cortex.
Sundström E; Mo LL
Pharmacol Toxicol; 2001 Jun; 88(6):342-8. PubMed ID: 11453375
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
Faucard R; Armand V; Héron A; Cochois V; Schwartz JC; Arrang JM
J Neurochem; 2006 Sep; 98(5):1487-96. PubMed ID: 16923161
[TBL] [Abstract][Full Text] [Related]
20. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
